Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Applying New MRI Technology to Improve Outcomes From Chemoradiotherapy Treatment for Adult Patients With Glioblastoma

NCT07443176 is registered in ClinicalTrials.gov with University of Aberdeen as lead sponsor.

NCT NCT07443176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07443176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Applying New MRI Technology to Improve Outcomes From Chemoradiotherapy Treatment for Adult Patients With Glioblastoma
Lead sponsor
University of Aberdeen
Phase
Observational
Overall status
Not yet recruiting
Start date
May 31, 2026
Completion date
December 31, 2027
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastom who grade 4